Global Hepatitis A Vaccine Market Insights, Forecast to 2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,900	145 Pages	QYResearch Group	March, 2022	QYR17024596

Best Price Guarantee
Price	from $4,900
Length	145 Pages
Publisher	QYResearch Group
Published Date	March, 2022
SKU	QYR17024596

Global Hepatitis A Vaccine Market Insights, Forecast to 2028

Summary

Market Analysis and Insights: Global Hepatitis A Vaccine Market
Due to the COVID-19 pandemic, the global Hepatitis A Vaccine market size is estimated to be worth US$ 735.86 million in 2022 and is forecast to a readjusted size of US$ 840.42 million by 2028 with a CAGR of 2.24% during the review period.
The global key manufacturers of Hepatitis A Vaccine include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, and AIM Vaccine etc. In 2021, the global top five players have a share approximately 81.09% in terms of revenue.
Global Hepatitis A Vaccine Scope and Segment
Hepatitis A Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis A Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
AIM Vaccine

Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine

Segment by Application
Government Institution
Private Sector
Other

Segment by Region
North America
U.S.
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia

Europe
Germany
France
U.K.
Italy
Russia

South America
Brazil

Middle East & Africa
Middle East
Africa

1 STUDY COVERAGE: 1.1 Hepatitis A Vaccine Product Introduction; 1.2 Market by Type; 1.2.1 Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028; 1.2.2 Inactivated Vaccine; 1.2.3 Live Attenuated Vaccine; 1.3 Market by Application; 1.4 Study Objectives; 1.5 Years Considered
2 EXECUTIVE SUMMARY: 2.1 Global Hepatitis A Vaccine Sales Estimates and Forecasts 2017-2028; 2.2 Global Hepatitis A Vaccine Revenue Estimates and Forecasts 2017-2028; 2.3 Global Hepatitis A Vaccine Revenue by Region: 2017 VS 2021 VS 2028; 2.4 Global Hepatitis A Vaccine Sales by Region; 2.4.1 Global Hepatitis A Vaccine Sales by Region (2017-2022); 2.4.2 Global Sales Hepatitis A Vaccine by Region (2023-2028); 2.5 Global Hepatitis A Vaccine Revenue by Region; 2.5.1 Global Hepatitis A Vaccine Revenue by Region (2017-2022); 2.5.2 Global Hepatitis A Vaccine Revenue by Region (2023-2028); 2.6 North America; 2.7 Europe; 2.8 Asia-Pacific; 2.9 South America; 2.10 Middle East & Africa
3 COMPETITION BY MANUFACTURERS: 3.1 Global Hepatitis A Vaccine Sales by Manufacturers; 3.1.1 Global Hepatitis A Vaccine Sales by Manufacturers (2020-2022); 3.1.2 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2020-2022); 3.1.3 Global Top Largest Manufacturers of Hepatitis A Vaccine in 2021; 3.2 Global Hepatitis A Vaccine Revenue by Manufacturers; 3.2.1 Global Hepatitis A Vaccine Revenue by Manufacturers (2020-2022); 3.2.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2020-2022); 3.2.3 Global Top Companies by Hepatitis A Vaccine Revenue in 2021; 3.3 Global Hepatitis A Vaccine Sales Price by Manufacturers (2020-2022); 3.4 Analysis of Competitive Landscape; 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI); 3.4.2 Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3); 3.4.3 Global Hepatitis A Vaccine Manufacturers Geographical Distribution; 3.5 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE: 4.1 Global Hepatitis A Vaccine Sales by Type; 4.1.1 Global Hepatitis A Vaccine Historical Sales by Type (2017-2022); 4.1.2 Global Hepatitis A Vaccine Forecasted Sales by Type (2023-2028); 4.1.3 Global Hepatitis A Vaccine Sales Market Share by Type (2017-2028); 4.2 Global Hepatitis A Vaccine Revenue by Type; 4.2.1 Global Hepatitis A Vaccine Historical Revenue by Type (2017-2022); 4.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Type (2023-2028); 4.2.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2017-2028); 4.3 Global Hepatitis A Vaccine Price by Type; 4.3.1 Global Hepatitis A Vaccine Price by Type (2017-2022); 4.3.2 Global Hepatitis A Vaccine Price Forecast by Type (2023-2028)
5 MARKET SIZE BY APPLICATION: 5.1 Global Hepatitis A Vaccine Sales by Application; 5.1.1 Global Hepatitis A Vaccine Historical Sales by Application (2017-2022); 5.1.2 Global Hepatitis A Vaccine Forecasted Sales by Application (2023-2028); 5.1.3 Global Hepatitis A Vaccine Sales Market Share by Application (2017-2028); 5.2 Global Hepatitis A Vaccine Revenue by Application; 5.2.1 Global Hepatitis A Vaccine Historical Revenue by Application (2017-2022); 5.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Application (2023-2028); 5.2.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2017-2028); 5.3 Global Hepatitis A Vaccine Price by Application; 5.3.1 Global Hepatitis A Vaccine Price by Application (2017-2022); 5.3.2 Global Hepatitis A Vaccine Price Forecast by Application (2023-2028)
6 NORTH AMERICA: 6.1 North America Hepatitis A Vaccine Market Size by Type; 6.1.1 North America Hepatitis A Vaccine Sales by Type (2017-2028); 6.1.2 North America Hepatitis A Vaccine Revenue by Type (2017-2028); 6.2 North America Hepatitis A Vaccine Market Size by Application; 6.3 North America Hepatitis A Vaccine Sales by Country; 6.3.1 North America Hepatitis A Vaccine Sales by Country (2017-2028); 6.3.2 North America Hepatitis A Vaccine Revenue by Country (2017-2028); 6.3.3 U.S.; 6.3.4 Canada; 6.3.5 Mexico
7 EUROPE: 7.1 Europe Hepatitis A Vaccine Market Size by Type; 7.1.1 Europe Hepatitis A Vaccine Sales by Type (2017-2028); 7.1.2 Europe Hepatitis A Vaccine Revenue by Type (2017-2028); 7.2 Europe Hepatitis A Vaccine Market Size by Application; 7.3 Europe Hepatitis A Vaccine Market Size by Country; 7.3.1 Europe Hepatitis A Vaccine Sales by Country (2017-2028); 7.3.2 Europe Hepatitis A Vaccine Revenue by Country (2017-2028); 7.3.3 Germany; 7.3.4 France; 7.3.5 U.K.; 7.3.6 Italy; 7.3.7 Russia
8 ASIA PACIFIC: 8.1 Asia Pacific Hepatitis A Vaccine Market Size by Type; 8.1.1 Asia Pacific Hepatitis A Vaccine Sales by Type (2017-2028); 8.1.2 Asia Pacific Hepatitis A Vaccine Revenue by Type (2017-2028); 8.2 Asia Pacific Hepatitis A Vaccine Market Size by Application; 8.3 Asia Pacific Hepatitis A Vaccine Market Size by Region; 8.3.1 Asia Pacific Hepatitis A Vaccine Sales by Region (2017-2028); 8.3.2 Asia Pacific Hepatitis A Vaccine Revenue by Region (2017-2028); 8.3.3 China; 8.3.4 Japan; 8.3.5 South Korea; 8.3.6 India; 8.3.7 Australia; 8.3.8 Southeast Asia
9 SOUTH AMERICA: 9.1 South America Hepatitis A Vaccine Market Size by Type; 9.1.1 South America Hepatitis A Vaccine Sales by Type (2017-2028); 9.1.2 South America Hepatitis A Vaccine Revenue by Type (2017-2028); 9.2 South America Hepatitis A Vaccine Market Size by Application; 9.3 South America Hepatitis A Vaccine Market Size by Country; 9.3.1 South America Hepatitis A Vaccine Sales by Country (2017-2028); 9.3.2 South America Hepatitis A Vaccine Revenue by Country (2017-2028); 9.3.3 Brazil
10 MIDDLE EAST AND AFRICA: 10.1 Middle East and Africa Hepatitis A Vaccine Market Size by Type; 10.1.1 Middle East and Africa Hepatitis A Vaccine Sales by Type (2017-2028); 10.1.2 Middle East and Africa Hepatitis A Vaccine Revenue by Type (2017-2028); 10.2 Middle East and Africa Hepatitis A Vaccine Market Size by Application; 10.3 Middle East and Africa Hepatitis A Vaccine Market Size by Country; 10.3.1 Middle East and Africa Hepatitis A Vaccine Sales by Country (2017-2028); 10.3.2 Middle East and Africa Hepatitis A Vaccine Revenue by Country (2017-2028); 10.3.3 Middle East; 10.3.4 Africa
11 CORPORATE PROFILE: 11.1 GSK; 11.1.1 GSK Corporation Information; 11.1.2 GSK Overview; 11.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.1.4 GSK Hepatitis A Vaccine Product Introduction; 11.2 Merck; 11.2.1 Merck Corporation Information; 11.2.2 Merck Overview; 11.2.3 Merck Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.2.4 Merck Hepatitis A Vaccine Product Introduction; 11.2.5 Merck Recent Developments; 11.3 Sanofi; 11.3.1 Sanofi Corporation Information; 11.3.2 Sanofi Overview; 11.3.3 Sanofi Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.3.4 Sanofi Hepatitis A Vaccine Product Introduction; 11.3.5 Sanofi Recent Developments; 11.4 Sinovac; 11.4.1 Sinovac Corporation Information; 11.4.2 Sinovac Overview; 11.4.3 Sinovac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.4.4 Sinovac Hepatitis A Vaccine Product Introduction; 11.4.5 Sinovac Recent Developments; 11.5 Zhejiang Pukang; 11.5.1 Zhejiang Pukang Corporation Information; 11.5.2 Zhejiang Pukang Overview; 11.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Introduction; 11.6 Changchun Institute of Biological; 11.6.1 Changchun Institute of Biological Corporation Information; 11.6.2 Changchun Institute of Biological Overview; 11.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Introduction; 11.7 KM Biologics; 11.7.1 KM Biologics Corporation Information; 11.7.2 KM Biologics Overview; 11.7.3 KM Biologics Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.7.4 KM Biologics Hepatitis A Vaccine Product Introduction; 11.7.5 KM Biologics Recent Developments; 11.8 IMBCAMS; 11.8.1 IMBCAMS Corporation Information; 11.8.2 IMBCAMS Overview; 11.8.3 IMBCAMS Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.8.4 IMBCAMS Hepatitis A Vaccine Product Introduction; 11.9 AIM Vaccine; 11.9.1 AIM Vaccine Corporation Information; 11.9.2 AIM Vaccine Overview; 11.9.3 AIM Vaccine Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.9.4 AIM Vaccine Hepatitis A Vaccine Product Introduction; 11.9.5 AIM Vaccine Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS: 12.1 Hepatitis A Vaccine Industry Chain Analysis; 12.2 Hepatitis A Vaccine Key Raw Materials; 12.2.1 Key Raw Materials; 12.2.2 Raw Materials Key Suppliers; 12.3 Hepatitis A Vaccine Production Mode & Process; 12.4 Hepatitis A Vaccine Sales and Marketing; 12.4.1 Hepatitis A Vaccine Sales Channels; 12.4.2 Hepatitis A Vaccine Distributors; 12.5 Hepatitis A Vaccine Customers
13 HEPATITIS A VACCINE MARKET DYNAMICS: 13.1.1 Hepatitis A Vaccine Industry Trends; 13.1.2 Hepatitis A Vaccine Market Drivers; 13.1.3 Hepatitis A Vaccine Market Challenges; 13.1.4 Hepatitis A Vaccine Market Restraints
14 KEY FINDINGS IN THE GLOBAL HEPATITIS A VACCINE STUDY
15 APPENDIX: 15.1 Research Methodology; 15.1.1 Methodology/Research Approach; 15.1.2 Data Source; 15.2 Author Details; 15.3 Disclaimer; List of Tables; Table 1. Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million); Table 2. Major Manufacturers of Live Attenuated Vaccine; Table 3. Global Hepatitis A Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million); Table 4. Global Hepatitis A Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million); Table 5. Global Hepatitis A Vaccine Sales by Region (2017-2022) & (K Unit); Table 6. Global Hepatitis A Vaccine Sales Market Share by Region (2017-2022); Table 7. Global Hepatitis A Vaccine Sales by Region (2023-2028) & (K Unit); Table 8. Global Hepatitis A Vaccine Sales Market Share by Region (2023-2028); Table 9. Global Hepatitis A Vaccine Revenue by Region (2017-2022) & (US$ Million); Table 10. Global Hepatitis A Vaccine Revenue Market Share by Region (2017-2022); Table 11. Global Hepatitis A Vaccine Revenue by Region (2023-2028) & (US$ Million); Table 12. Global Hepatitis A Vaccine Revenue Market Share by Region (2023-2028)